Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

The decision to discontinue further clinical development of Acasunlimab does not impact Genmab’s full‑year 2025 financial guidance, the company said. ・Genmab assumed sole responsibility for the ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, Partnership, and Purpose.

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Denmark's Genmab has decided not to continue the development of a drug for cancer, acasunlimab, which had reached phase 3 testing, after a review of its medicines pipeline. The decision to end the ...

New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin D biology and ...

Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure, and access to care.

The extreme weight loss seen in many late-stage cancer patients, known as cachexia, is far more than a cosmetic side effect.

Share on Pinterest Scientists are looking at the effects of the keto diet on cancer therapies. Dulin/Getty Images A ketogenic diet can interact with certain cancer therapies to block the development ...

Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...